AA
CRBU icon

Ancora Advisors’s Caribou Biosciences CRBU Stock Holding History

Ancora Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,000
Closed -$31K – 1980
2025
Q1 		$31K Sell
34,000
-24,000
-41% -$31.2K ﹤0.01% 1111
2024
Q4 		$92.2K Buy
58,000
+8,000
+16% +$16.1K ﹤0.01% 865
2024
Q3 		$98K Buy
50,000
+20,000
+67% +$41K ﹤0.01% 824
2024
Q2 		$49.2K Buy
30,000
+10,000
+50% +$32K ﹤0.01% 948
2024
Q1 		$103K Buy
+20,000
New +$123K ﹤0.01% 802
2023
Q2 		– Sell
-25
Closed -$133 – 1818
2023
Q1 		$133 Buy
+25
New +$156 ﹤0.01% 1871

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ancora Advisors's CRBU Position: Q2 2025 in Review

Ancora Advisors sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 34,000 shares — an estimated $31K sold.

Ancora Advisors first reported a position in CRBU in Q1 2023 and held it in 6 quarters. The position peaked at $103K in Q1 2024. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • Ancora Advisors reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • Ancora Advisors sold 34,000 Caribou Biosciences shares in Q2 2025, an estimated $31K.
  • Ancora Advisors first reported a position in Caribou Biosciences in Q1 2023 and held it in 6 quarters.
  • Ancora Advisors's Caribou Biosciences position peaked at $103K in Q1 2024.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on Ancora Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.